Search For "pharma"
Piramal reports 18 pc jump in Q2 net profit at Rs 569 crore
Updated : 6 years, 4 months ago IST
Mumbai (Maharashtra) [India], Oct 21 (ANI): Piramal Enterprises Ltd on Monday reported an 18 per cent jump in its net profit to Rs 569 crore for Q2 FY20 year-on-year and by 19 per cent to Rs 1,029 crore for H1 FY20.
Read More
KTR seeks Centre's assistance for Hyderabad pharma city project
Updated : 6 years, 4 months ago IST
Hyderabad (Telangana) [India], Oct 20 (ANI): Telangana Rashtra Samithi (TRS) working president KT Rama Rao on Sunday wrote to Union Ministers Piyush Goyal and Dharmendra Pradhan seeking assistance for the Hyderabad Pharma City (HPC) project, proposed to be developed near here.
Read More
Granules India to exit from China joint venture
Updated : 6 years, 5 months ago IST
Hyderabad (Telangana) [India], Oct 14 (ANI): Granules India Ltd said on Monday it will divest its entire equity shareholding in its Chinese joint venture Granules Biocause Pharmaceuticals.
Read More
Morepen Labs adds three new drugs - Rivaroxaban, Vildagliptin and UDCA to
Updated : 6 years, 5 months ago IST
New Delhi [India] Oct 14(ANI/NewsVoir): Morepen Laboratories Ltd has developed and added three blockbuster drugs to its portfolio of Active Pharmaceutical Ingredients (APIs) for sale in domestic and global markets.
Read More
Japan's PMDA issues GMP certificate to Lupin's unit at Mandideep facility
Updated : 6 years, 5 months ago IST
Mumbai (Maharashtra) [India], Oct 9 (ANI): Pharma major Lupin Ltd on Wednesday announced the receipt of good manufacturing practice (GMP) certificate from the Pharmaceutical and Medical Devices Agency (PMDA) of Japan for its active pharmaceutical ingredient facility at Mandideep in Madhya Pr
Read More
Sensex drops by 141 points, pharma stocks nosedive
Updated : 6 years, 5 months ago IST
Mumbai (Maharashtra) [India], Oct 7 (ANI): Equities wiped out early gains on Monday as selling pressure in the closing hour weighed in across the board.
Read More
US FDA issues warning letter for Glenmark Pharmaceuticals facility in Badd
Updated : 6 years, 5 months ago IST
Mumbai (Maharashtra) [India], Oct 7 (ANI): The US Food and Drug Administration (US FDA) has issued a warning letter to Glenmark Pharmaceuticals for breach of norms at its facility at Baddi in Himachal Pradesh.
Read More
Margin pressure to persist for pharma companies: ICRA
Updated : 6 years, 5 months ago IST
New Delhi [India], Oct 5 (ANI): The growth and profitability of Indian pharmaceutical companies in current financial year will be constrained by regulatory interventions like price controls in domestic market and compulsory genericisation in overseas market, according to ICRA Ratings.
Read More
US Commerce Secretary Ross to meet Goyal for thrashing out a trade deal
Updated : 6 years, 5 months ago IST
New Delhi [India], Oct 3 (ANI): US Commerce Secretary Wilbur Ross said on Thursday he will hold talks with Commerce and Industry Minister Piyush Goyal to trash out a trade deal on farm goods and pharmaceuticals.
Read More
Lupin closes offloading of Japanese subsidiary Kyowa Criticare to Neopharm
Updated : 6 years, 5 months ago IST
Mumbai (Maharashtra) [India], Sep 30 (ANI): Pharma major Lupin Ltd said on Monday it has closed a definitive agreement for the sale of its Japanese injectables business and related assets to Neo Ala Co Ltd, a wholly-owned subsidiary of Neopharma Group which is the UAE's largest pharmaceutica
Read More
SEBI imposes Rs 22.7 crore fine on Aurobindo Pharma for insider trading
Updated : 6 years, 5 months ago IST
Mumbai (Maharashtra) [India], Sep 24 (ANI): The Securities Exchange Board of India (SEBI) has imposed penalties of Rs 22.7 crore on Aurobindo Pharma, its related entities and promoters for violating insider trading rules with respect to a licensing deal it had entered with Pfizer in 2009.
Read More
Strides Pharma board approves additional investment up to $40 million
Updated : 6 years, 5 months ago IST
Bengaluru (Karnataka) [India], Sept 20 (ANI): Strides Pharma Science said on Friday that its board of directors has approved an additional investment of up to 40 million dollars (about Rs 290 crore) over the next two years for a controlling stake in its associate company Stelis Biopharma.
Read More